Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2011

View Archived Issues

Japanese scientists describe miRNAs in plasma and synovial fluid as biomarkers for RA and OA

AM-432 is active in models of inflammatory respiratory conditions

New prostanoid EP4 receptor antagonist MF-592 has promising preclinical profile

Activators of ERK signaling may provide new therapeutic approach for HD

Lapatinib plus capecitabine does not improve survival of patients with metastatic pancreatic cancer

Phase Ib trials assess drozitumab-based combination regimens in advanced mCRC

Gilead Sciences presents new antiviral compounds

Soligenix and University of Colorado enter agreement for thermostable vaccines

Eisai establishes subsidiary to develop next-generation cancer drugs

Novel agonists of cannabinoid CB1 and CB2 receptors disclosed

New adenosine A2B receptor antagonists claimed by PGxHealth

Bayer and Zydus Cadila form joint company in India to optimize product portfolios

Arena Pharma provides update on lorcaserin and its pipeline

Pathway Therapeutics divulges novel PI3K inhibitors

MorphoSys receives milestone payment from OncoMed Pharma for phase I OMP-59R5 trial

CSL Behring's Berinert approved in Israel for acute HAE

Pfizer issues milestone payment to MorphoSys regarding phase I testing of HuCAL-derived antibody

Antisoma discontinues development of AS-1413 in secondary AML

FDA approves Menveo vaccine for children but refuses sBLA for use in infants

Collaboration launched to develop biomarker predicting response to PF-01367338

Rituxan approved in U.S. for first-line maintenance use in follicular lymphoma

AMT receives grant to develop AMT-021 for acute intermittent porphyria

Verona Pharma seeks U.K. clearance for clinical trials of RPL-554

European Commission approves Johnson & Johnson's acquisition of Crucell

FDA approves Gralise for once-daily treatment of postherpetic neuralgia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...